<p>Costamare（纽约证券交易所代码：CMRE）在过去一个月内股价上涨约 26%，在过去三个月内上涨 35%，尽管年收入有所下降，依然表现强劲。</p>
<p>查看我们对 Costamare 的最新分析。</p>
<p>放眼全局，Costamare 年初至今约 21% 的股价回报和约 73% 的 1 年总股东回报表明，随着投资者重新评估公司的盈利韧性和资产价值，势头正在稳步增强。</p>
<p>如果 Costamare 最近的走势让你思考在航运及其他领域还有哪些股票可能正在蓄势待发，那么现在可能是探索高内部持股的快速增长股票的好时机。</p>
<p>但随着收入收缩，分析师目标价低于当前价格，估值筛选显示有限的价值吸引力，Costamare 是否仍在折价交易，还是市场已经将其未来增长的许多部分考虑在内？</p>
<h2>最受欢迎的叙述：33.3% 被高估</h2>
<p>与公允价值叙述的 12.25 美元相比，Costamare 最后的收盘价为 16.33 美元，意味着投资者为其盈利韧性故事支付了溢价。</p>
<p><em>分析师对 Costamare 的共识目标价为 10.15 美元，基于他们对未来盈利增长、利润率和其他风险因素的预期。为了同意分析师的共识，你需要相信到 2028 年，收入将达到 4.483 亿美元，盈利将达到 2.852 亿美元，假设你使用 12.3% 的折现率，其市盈率将为 6.1 倍。</em></p>
<p>阅读完整叙述。</p>
<p>想知道是什么支撑了尽管收入缩减但仍保持这一估值？叙述依赖于利润扩张、韧性盈利和挑战当今市场假设的未来倍数。</p>
<p><strong>结果：公允价值为 12.25 美元（被高估）</strong></p>
<p>完整阅读叙述，了解预测背后的原因。</p>
<p>然而，如果合同收入、船队更新和海王星租赁使盈利保持比预期更稳定，那么今天的谨慎叙述可能过于悲观。</p>
<p>了解 Costamare 叙述的关键风险。</p>
<h2>价值的另一种角度</h2>
<p>从简单的盈利倍数来看，故事显得不同。Costamare 的市盈率约为 6.6 倍，低于更广泛的美国市场的 18.7 倍，但高于接近同行的约 5.4 倍。公允比率接近 9.3 倍，市场是在低估韧性还是在为周期性高峰支付过高的价格？</p>
<p>查看数字对这一价格的看法——在我们的估值分析中了解更多。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/cc56f70a-acc7-4628-9fd6-60dd2893daed/chart/pe-multiple-vs-industry?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/cc56f70a-acc7-4628-9fd6-60dd2893daed/chart/pe-multiple-vs-industry"/></p>
<p>截至 2025 年 12 月的 NYSE:CMRE 市盈率</p>
<h2>自建 Costamare 叙述</h2>
<p>如果这个视角与你的看法不太吻合，或者你更愿意从基本原则出发，你可以在几分钟内构建个性化叙述，按照你的方式进行。</p>
<p>进行 Costamare 研究的一个很好的起点是我们的分析，强调 1 个关键回报和 4 个重要警示信号，这些可能会影响你的投资决策。</p>
<h2>寻找更多投资想法？</h2>
<p>一些投资者定期建立他们的观察名单。你可以花几分钟在 Simply Wall Street 上扫描新机会，抢在其他人之前。</p>
<ul>
<li>通过使用这些 3571 只财务状况良好的便士股票，提前识别潜在的多倍收益股票，研究那些尚未被广泛关注的增长机会。</li>
<li>通过使用这 30 只医疗保健 AI 股票，探索医疗保健领域的结构性变化，寻找与医疗数据和 AI 合作的公司。</li>
<li>通过这些 15 只收益率超过 3% 的分红股票研究收入机会，这可能帮助你关注那些有支付分红记录的公司。</li>
</ul>
<p><em>这篇文章由 Simply Wall St 撰写，性质一般。<strong>我们提供基于历史数据和分析师预测的评论，仅使用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑你的目标或财务状况。我们旨在为你提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>

CMRE

<p>Costamare（纽约证券交易所代码：CMRE）在过去一个月股价上涨了 26%，三个月上涨了 35%，尽管收入有所下降。分析师认为该股票被高估，合理价值为 12.25 美元，而其最后收盘价为 16.33 美元。基于未来收益和风险因素，市场共识目标价为 10.15 美元。叙述强调了盈利的韧性和利润率的扩张，但仍然存在市场是否为周期性高峰支付过高价格的问题</p>

<p>Costamare (NYSE:CMRE) has quietly delivered a strong run, with the stock up about 26% over the past month and 35% in the past 3 months, despite declining annual revenue.</p>
<div class="lb-trans"><p>Costamare（纽约证券交易所代码：CMRE）在过去一个月内股价上涨约 26%，在过去三个月内上涨 35%，尽管年收入有所下降，依然表现强劲。</p>
</div><p>See our latest analysis for Costamare.</p>
<div class="lb-trans"><p>查看我们对 Costamare 的最新分析。</p>
</div><p>Zooming out, Costamare’s roughly 21% year to date share price return and powerful 1 year total shareholder return of about 73% suggest momentum is firmly building as investors reassess the company’s earnings resilience and asset values.</p>
<div class="lb-trans"><p>放眼全局，Costamare 年初至今约 21% 的股价回报和约 73% 的 1 年总股东回报表明，随着投资者重新评估公司的盈利韧性和资产价值，势头正在稳步增强。</p>
</div><p>If Costamare’s recent move has you thinking about what else might be gathering steam in shipping and beyond, this could be a good moment to explore fast growing stocks with high insider ownership.</p>
<div class="lb-trans"><p>如果 Costamare 最近的走势让你思考在航运及其他领域还有哪些股票可能正在蓄势待发，那么现在可能是探索高内部持股的快速增长股票的好时机。</p>
</div><p>But with revenue contracting, analyst targets sitting below the current price, and valuation screens flagging limited value appeal, is Costamare still trading at a discount or is the market already baking in much of its future growth?</p>
<div class="lb-trans"><p>但随着收入收缩，分析师目标价低于当前价格，估值筛选显示有限的价值吸引力，Costamare 是否仍在折价交易，还是市场已经将其未来增长的许多部分考虑在内？</p>
</div><h2>Most Popular Narrative: 33.3% Overvalued</h2>
<div class="lb-trans"><h2>最受欢迎的叙述：33.3% 被高估</h2>
</div><p>Compared to the narrative fair value of $12.25, Costamare’s last close at $16.33 implies investors are paying up for its earnings resilience story.</p>
<div class="lb-trans"><p>与公允价值叙述的 12.25 美元相比，Costamare 最后的收盘价为 16.33 美元，意味着投资者为其盈利韧性故事支付了溢价。</p>
</div><p><em>The analysts have a consensus price target of $10.15 for Costamare based on their expectations of its future earnings growth, profit margins and other risk factors. In order for you to agree with the analyst's consensus, you would need to believe that by 2028, revenues will be $448.3 million, earnings will come to $285.2 million, and it would be trading on a PE ratio of 6.1x, assuming you use a discount rate of 12.3%.</em></p>
<div class="lb-trans"><p><em>分析师对 Costamare 的共识目标价为 10.15 美元，基于他们对未来盈利增长、利润率和其他风险因素的预期。为了同意分析师的共识，你需要相信到 2028 年，收入将达到 4.483 亿美元，盈利将达到 2.852 亿美元，假设你使用 12.3% 的折现率，其市盈率将为 6.1 倍。</em></p>
</div><p>Read the complete narrative.</p>
<div class="lb-trans"><p>阅读完整叙述。</p>
</div><p>Want to see what holds this valuation together despite shrinking revenues? The narrative leans on margin expansion, resilient earnings, and a future multiple that challenges today’s market assumptions.</p>
<div class="lb-trans"><p>想知道是什么支撑了尽管收入缩减但仍保持这一估值？叙述依赖于利润扩张、韧性盈利和挑战当今市场假设的未来倍数。</p>
</div><p><strong>Result: Fair Value of $12.25 (OVERVALUED)</strong></p>
<div class="lb-trans"><p><strong>结果：公允价值为 12.25 美元（被高估）</strong></p>
</div><p>Have a read of the narrative in full and understand what's behind the forecasts.</p>
<div class="lb-trans"><p>完整阅读叙述，了解预测背后的原因。</p>
</div><p>However, if contracted revenues, fleet renewal and Neptune leasing keep earnings steadier than expected, today’s cautious narrative could prove too pessimistic.</p>
<div class="lb-trans"><p>然而，如果合同收入、船队更新和海王星租赁使盈利保持比预期更稳定，那么今天的谨慎叙述可能过于悲观。</p>
</div><p>Find out about the key risks to this Costamare narrative.</p>
<div class="lb-trans"><p>了解 Costamare 叙述的关键风险。</p>
</div><h2>Another Angle on Value</h2>
<div class="lb-trans"><h2>价值的另一种角度</h2>
</div><p>On simple earnings multiples, the story looks different. Costamare trades on about 6.6 times earnings, cheaper than the wider US market at 18.7 times but richer than close peers at roughly 5.4 times. With a fair ratio near 9.3 times, is the market underpricing resilience or overpaying for a cyclical spike?</p>
<div class="lb-trans"><p>从简单的盈利倍数来看，故事显得不同。Costamare 的市盈率约为 6.6 倍，低于更广泛的美国市场的 18.7 倍，但高于接近同行的约 5.4 倍。公允比率接近 9.3 倍，市场是在低估韧性还是在为周期性高峰支付过高的价格？</p>
</div><p>See what the numbers say about this price — find out in our valuation breakdown.</p>
<div class="lb-trans"><p>查看数字对这一价格的看法——在我们的估值分析中了解更多。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/cc56f70a-acc7-4628-9fd6-60dd2893daed/chart/pe-multiple-vs-industry" alt="" original-src="https://images.simplywall.st/company/cc56f70a-acc7-4628-9fd6-60dd2893daed/chart/pe-multiple-vs-industry"/></p>
<p>NYSE:CMRE PE Ratio as at Dec 2025</p>
<div class="lb-trans"><p>截至 2025 年 12 月的 NYSE:CMRE 市盈率</p>
</div><h2>Build Your Own Costamare Narrative</h2>
<div class="lb-trans"><h2>自建 Costamare 叙述</h2>
</div><p>If this perspective does not quite fit your view, or you would rather work from first principles, you can build a personalized narrative in minutes, Do it your way.</p>
<div class="lb-trans"><p>如果这个视角与你的看法不太吻合，或者你更愿意从基本原则出发，你可以在几分钟内构建个性化叙述，按照你的方式进行。</p>
</div><p>A great starting point for your Costamare research is our analysis highlighting 1 key reward and 4 important warning signs that could impact your investment decision.</p>
<div class="lb-trans"><p>进行 Costamare 研究的一个很好的起点是我们的分析，强调 1 个关键回报和 4 个重要警示信号，这些可能会影响你的投资决策。</p>
</div><h2>Looking for more investment ideas?</h2>
<div class="lb-trans"><h2>寻找更多投资想法？</h2>
</div><p>Some investors regularly build their watchlist. You can take a few minutes to scan fresh opportunities on Simply Wall Street before others do the same.</p>
<div class="lb-trans"><p>一些投资者定期建立他们的观察名单。你可以花几分钟在 Simply Wall Street 上扫描新机会，抢在其他人之前。</p>
</div><ul>
<li>Identify potential multi-baggers early by using these 3571 penny stocks with strong financials to research under-the-radar growth opportunities before they become widely followed.</li>
<li>Explore structural shifts in healthcare by using these 30 healthcare AI stocks to find companies that are working with medical data and AI.</li>
<li>Research income opportunities through these 15 dividend stocks with yields &gt; 3% that may help you focus on companies with a track record of paying dividends.</li>
</ul>
<div class="lb-trans"><ul>
<li>通过使用这些 3571 只财务状况良好的便士股票，提前识别潜在的多倍收益股票，研究那些尚未被广泛关注的增长机会。</li>
<li>通过使用这 30 只医疗保健 AI 股票，探索医疗保健领域的结构性变化，寻找与医疗数据和 AI 合作的公司。</li>
<li>通过这些 15 只收益率超过 3% 的分红股票研究收入机会，这可能帮助你关注那些有支付分红记录的公司。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>这篇文章由 Simply Wall St 撰写，性质一般。<strong>我们提供基于历史数据和分析师预测的评论，仅使用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑你的目标或财务状况。我们旨在为你提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div>

Costamare (NYSE:CMRE)：在经历了数月的强劲股价上涨后重新审视其估值